1. Home
  2. YXT vs RENB Comparison

YXT vs RENB Comparison

Compare YXT & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YXT
  • RENB
  • Stock Information
  • Founded
  • YXT 2011
  • RENB 2011
  • Country
  • YXT China
  • RENB United States
  • Employees
  • YXT N/A
  • RENB N/A
  • Industry
  • YXT
  • RENB Biotechnology: Pharmaceutical Preparations
  • Sector
  • YXT
  • RENB Health Care
  • Exchange
  • YXT NYSE
  • RENB Nasdaq
  • Market Cap
  • YXT 129.2M
  • RENB 121.3M
  • IPO Year
  • YXT 2024
  • RENB N/A
  • Fundamental
  • Price
  • YXT $2.03
  • RENB $0.71
  • Analyst Decision
  • YXT
  • RENB
  • Analyst Count
  • YXT 0
  • RENB 0
  • Target Price
  • YXT N/A
  • RENB N/A
  • AVG Volume (30 Days)
  • YXT 94.4K
  • RENB 1.8M
  • Earning Date
  • YXT 02-21-2025
  • RENB 02-12-2025
  • Dividend Yield
  • YXT N/A
  • RENB N/A
  • EPS Growth
  • YXT N/A
  • RENB N/A
  • EPS
  • YXT 3.06
  • RENB N/A
  • Revenue
  • YXT $48,030,651.00
  • RENB N/A
  • Revenue This Year
  • YXT N/A
  • RENB N/A
  • Revenue Next Year
  • YXT N/A
  • RENB N/A
  • P/E Ratio
  • YXT $0.65
  • RENB N/A
  • Revenue Growth
  • YXT N/A
  • RENB N/A
  • 52 Week Low
  • YXT $1.82
  • RENB $0.40
  • 52 Week High
  • YXT $11.00
  • RENB $5.25
  • Technical
  • Relative Strength Index (RSI)
  • YXT N/A
  • RENB 39.34
  • Support Level
  • YXT N/A
  • RENB $0.70
  • Resistance Level
  • YXT N/A
  • RENB $0.94
  • Average True Range (ATR)
  • YXT 0.00
  • RENB 0.14
  • MACD
  • YXT 0.00
  • RENB -0.03
  • Stochastic Oscillator
  • YXT 0.00
  • RENB 2.57

About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS

Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Share on Social Networks: